Thiamine (Vitamin B1) — Complete Clinical Reference
SIGN protocol, Wernicke grading, beriberi types, benfotiamine pharmacology, and thiamine-glucose interaction.
1. Biochemistry and Metabolic Roles
Thiamine (vitamin B1) is a water-soluble B-vitamin that functions as an essential cofactor — as thiamine pyrophosphate (TPP), its active form — in three critical enzymatic reactions: pyruvate dehydrogenase (glycolysis → Krebs cycle entry), α-ketoglutarate dehydrogenase (Krebs cycle), and transketolase (pentose phosphate pathway). These reactions are central to carbohydrate metabolism and neuronal energy production.
Unlike fat-soluble vitamins, thiamine is not stored in large quantities. Total body stores are only 25–30 mg, primarily in skeletal muscle, heart, liver, and kidney. With a biological half-life of ~18 days, clinically significant deficiency can develop within 2–3 weeks of dietary absence or increased demand — making it uniquely dangerous in acute settings.
| Form | Water Solubility | Bioavailability | Key Feature |
|---|---|---|---|
| Thiamine HCl | High (water-soluble) | Standard; ~3.7% at 100 mg dose | Universal; first-line IV/IM for emergencies |
| Benfotiamine | Low (fat-soluble prodrug) | 3.6× higher than HCl; better intracellular | Superior for neuropathy; oral only |
| Thiamine Pyrophosphate (TPP) | High | Active coenzyme; moderate | Specialty; combination products |
| Thiamine Mononitrate | Moderate | Lower than HCl | Food fortification; OTC supplements |
2. Wernicke–Korsakoff Syndrome
Wernicke encephalopathy (WE) is an acute neurological emergency caused by thiamine deficiency, classically occurring in alcoholics but increasingly recognised in non-alcoholic patients — bariatric surgery, hyperemesis gravidarum, malignancy, prolonged TPN, and eating disorders. It is dramatically underdiagnosed in clinical practice.
The Classic Triad — and Its Limitations
The classic Wernicke triad (confusion/encephalopathy, ophthalmoplegia, ataxia) is present in only ~16% of confirmed cases at autopsy. Any one feature in a susceptible patient is sufficient clinical justification for emergency IV thiamine. The cost of under-treating is catastrophic; the cost of over-treating is negligible.
SIGN Protocol (Recommended)
| Clinical Scenario | Dose | Route | Duration |
|---|---|---|---|
| Active Wernicke Encephalopathy | 500 mg TDS | IV (100 mL NS, 30 min) | 2–3 days minimum |
| Post-loading maintenance | 250 mg once daily | IV or IM | 5 days |
| Oral step-down | 100 mg TDS | Oral | Indefinitely in alcoholics |
| Alcohol detox (high risk) | 500 mg TDS | IV | Until eating normally |
| Alcohol detox (standard) | 250 mg once daily | IV or IM | 3–5 days |
| Prophylaxis (at-risk outpatient) | 100 mg TDS oral | Oral | Ongoing |
3. Beriberi — Still Clinically Relevant
Beriberi remains an important diagnosis in India (rice-eating populations in eastern and northeastern states, institutional settings, alcoholics), parts of Southeast Asia, and increasingly in bariatric post-operative patients globally. It manifests in two major forms:
Wet Beriberi (Cardiac)
High-output cardiac failure — the pathognomonic presentation. Thiamine deficiency causes peripheral vasodilatation, sodium and water retention, and compensatory high cardiac output, eventually leading to cardiac decompensation. Clinical features: bounding pulse, warm peripheries, oedema, elevated JVP, cardiomegaly. The response to IV thiamine within 24–48 hours is so dramatic that it serves as a diagnostic test in itself.
Dry Beriberi (Neurological)
Peripheral neuropathy — symmetric, distal, ascending motor and sensory neuropathy, predominantly affecting the lower limbs. Unlike wet beriberi, recovery from dry beriberi is slow and incomplete. The pathophysiology involves axonal degeneration rather than the purely functional cardiac changes of wet beriberi.
| Type | Loading Dose | Route | Duration | Notes |
|---|---|---|---|---|
| Wet Beriberi | 100 mg | IV daily | 7–14 days | ECG monitor; response in 24–48h diagnostic |
| Dry Beriberi | 50–100 mg | IV or IM daily | 14 days → oral | Recovery slower; continue oral for months |
| Infantile Beriberi | 10–25 mg | IV or IM | 7 days | Treat lactating mother concurrently: 100 mg TDS |
| Maintenance (all) | 25–50 mg | Oral TDS | 6 weeks → dietary | Address underlying nutritional cause |
4. Benfotiamine — Fat-Soluble Thiamine for Neuropathy
Benfotiamine (S-benzoylthiamine O-monophosphate) is an open-chain fat-soluble derivative of thiamine with fundamentally different pharmacokinetics. Unlike water-soluble thiamine HCl, benfotiamine is absorbed via passive diffusion through lipid membranes, achieving intracellular thiamine concentrations 3.6× higher than equivalent doses of thiamine HCl.
This superior intracellular bioavailability is clinically relevant for conditions where intracellular thiamine depletion drives pathology — particularly diabetic peripheral neuropathy and alcoholic neuropathy. Benfotiamine activates transketolase, shunting excess glucose metabolites away from pathological pathways (polyol, hexosamine, PKC, and AGE pathways) that mediate diabetic microvascular damage.
Benfotiamine Dosing
| Indication | Loading | Maintenance | Duration |
|---|---|---|---|
| Diabetic Peripheral Neuropathy | 300 mg BD | 150 mg BD | Loading 4–6 weeks; then indefinite maintenance |
| Alcoholic Neuropathy | 300–600 mg BD | 150–300 mg BD | 4 weeks loading; long-term if ongoing alcohol use |
| Thiamine Deficiency Neuropathy | 300 mg BD | 150 mg BD | Until neurological improvement plateaus |
5. The Thiamine–Glucose Interaction — A Critical Safety Rule
This is one of the most clinically important drug-nutrient interactions in emergency medicine. When a thiamine-deficient patient receives IV glucose (dextrose), the glucose load dramatically increases metabolic demand for thiamine. If thiamine stores are already critically depleted, this metabolic surge can precipitate acute Wernicke encephalopathy within hours.
6. Thiamine in Pregnancy and Hyperemesis Gravidarum
Pregnancy increases thiamine requirements (RDA: 1.4 mg/day). The critical clinical scenario is hyperemesis gravidarum (HG) — severe persistent vomiting preventing oral intake — which can cause clinically significant thiamine depletion within 2–3 weeks. Every patient admitted with hyperemesis gravidarum and receiving IV fluids should receive concurrent IV thiamine.
| Context | Dose | Route | Notes |
|---|---|---|---|
| Hyperemesis (routine prevention) | 100 mg daily | IV or IM | While on IV dextrose rehydration |
| Hyperemesis + Wernicke's signs | 500 mg TDS × 3 days | IV | Emergency protocol — same as non-pregnant Wernicke's |
| Maintenance (HG resolving) | 50–100 mg TDS | Oral | Until normal diet resumed |
| RDA (all pregnancy) | 1.4 mg/day | Oral (prenatal vitamins) | All prenatal supplements contain thiamine |
7. Laboratory Reference Values
Whole blood thiamine (as thiamine diphosphate, TDP) is the most reliable measure of thiamine status. Erythrocyte transketolase activity and ETKAC are functional measures that reflect thiamine availability at the enzymatic level.
| Test | Normal | Deficiency | Notes |
|---|---|---|---|
| Whole blood thiamine (TDP) | 70–180 nmol/L | <70 nmol/L | Most reliable; gold standard |
| Serum/plasma thiamine | 8–30 nmol/L | <8 nmol/L | Less reliable; reflects recent intake |
| ETKAC (activation coefficient) | <1.15 | >1.25 (functional deficiency) | Measures enzyme saturation; not rapid |
| Urinary thiamine | >100 mcg/g creatinine | <27 mcg/g creatinine | 24-hour collection; reflects intake |